TG Therapeutics, Inc. (TGTX)
43.39
+2.44
(+5.96%)
USD |
NASDAQ |
Jun 09, 16:00
43.38
-0.01
(-0.02%)
After-Hours: 19:23
TG Therapeutics SG&A Expense (Quarterly) : 88.22M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 41.01M |
| MAIA Biotechnology, Inc. | 3.425M |
| Vericel Corp. | 49.23M |
| Catalyst Pharmaceuticals, Inc. | 43.52M |
| United Therapeutics Corp. | 156.60M |